Clinical Trial Update: Sentinel and/or Axillary Lymph Node Biopsy With or Without Axillary Reverse Mapping in Reducing Incidence and Severity of Arm Lymphedema in Stage 0-2 Patients. [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating sentinel lymph node biopsy with or without axillary reverse mapping to reduce arm lymphedema in early-stage breast cancer; the study wa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Lymphedema

Snippet

Sponsor: University of Southern California | Conditions: Lymphedema, Recurrent Breast Cancer | Phase 2 | Status: TERMINATED | Results posted: 2014-08-01